Author

Alexander Balfour Mullen

Observed names: A B Mullen, A Mullen, A. B. MULLEN, A. B. Mullen, A.B Mullen, A.B. Mullen, Alex B Mullen, Alex B. Mullen, Alexander B Mullen, Alexander B. Mullen, Alexander Mullen, Mullen, Mullen, A.B., Mullen, Alexander B., Prof Alexander Mullen

Institution: University of Strathclyde

Observed institutions: University of Nottingham, University of Strathclyde, University of Glasgow

ORCID: 0000-0001-7475-5543

Observed ORCID: 0000-0001-7475-5543

OpenAlex ID: A5011655487

Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection

2009 · Jamie F.S. Mann, Eisin Shakir, et al. · Vaccine · 166

Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity

2006 · Jamie F.S. Mann, Hannah E. Scales, et al. · Methods · 99

Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis

1997 · A B Mullen, K C Carter, et al. · Antimicrobial Agents and Chemotherapy · 91

Probing polydopamine adhesion to protein and polymer films: microscopic and spectroscopic evaluation

2017 · David Mallinson, Alexander B. Mullen, et al. · Journal of Materials Science · 86

PDF

An association between socioeconomic deprivation and primary care antibiotic prescribing in Scotland

2013 · J. R. Covvey, B. F. Johnson, et al. · Journal of Antimicrobial Chemotherapy · 73

PDF

In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets

2010 · Manish Ghimire, Lee Ann Hodges, et al. · Journal of Controlled Release · 73

Lipid-based nanoparticles for cancer treatment

2018 · Mohammad A. Obeid, Rothwelle J. Tate, et al. · Elsevier eBooks · 71

Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin

2004 · Jamie F.S. Mann, Valerie A. Ferro, et al. · Vaccine · 71

Antibiotic treatment of urinary tract infection by community pharmacists: a cross-sectional study

2013 · Jill L Booth, Alexander B Mullen, et al. · British Journal of General Practice · 65

PDF

The In Vivo Susceptibility of Leishmania donovani to Sodium Stibogluconate Is Drug Specific and Can Be Reversed by Inhibiting Glutathione Biosynthesis

2003 · K. C. Carter, S. Sundar, et al. · Antimicrobial Agents and Chemotherapy · 64

PDF

A comparison of medication adherence/persistence for asthma and chronic obstructive pulmonary disease in the United Kingdom

2014 · J. R. Covvey, A. B. Mullen, et al. · International Journal of Clinical Practice · 56

PDF

Efficacy of an anti-fertility vaccine based on mammalian gonadotrophin releasing hormone (GnRH-I)—a histological comparison in male animals

2004 · V.A Ferro, M.A.H Khan, et al. · Veterinary Immunology and Immunopathology · 56

Visceral Leishmaniasis in the BALB/c Mouse: A Comparison of the Efficacy of a Nonionic Surfactant Formulation of Sodium Stibogluconate with Those of Three Proprietary Formulations of Amphotericin B

1998 · A. B. Mullen, A. J. Baillie, et al. · Antimicrobial Agents and Chemotherapy · 55

The effects of hydration media on the characteristics of non-ionic surfactant vesicles (NISV) prepared by microfluidics

2016 · Mohammad A. Obeid, Ibrahim Khadra, et al. · International Journal of Pharmaceutics · 52

PDF

Resistance ofLeishmania donovanito Sodium Stibogluconate Is Related to the Expression of Host and Parasite γ-Glutamylcysteine Synthetase

2005 · K. C. Carter, S. Hutchison, et al. · Antimicrobial Agents and Chemotherapy · 51

The efficacy of aerosol treatment with non-ionic surfactant vesicles containing amphotericin B in rodent models of leishmaniasis and pulmonary aspergillosis infection

2012 · M. Alsaadi, J.L. Italia, et al. · Journal of Controlled Release · 50

Identification of the benzodiazepines as a new class of antileishmanial agent

2006 · Rachel L. Clark, Katharine C. Carter, et al. · Bioorganic & Medicinal Chemistry Letters · 48

Formulation of Nonionic Surfactant Vesicles (NISV) Prepared by Microfluidics for Therapeutic Delivery of siRNA into Cancer Cells

2017 · Mohammad A. Obeid, Ashref Elburi, et al. · Molecular Pharmaceutics · 47

Optimizing efficacy of mucosal vaccines

2012 · Ayman Gebril, Manal Alsaadi, et al. · Expert Review of Vaccines · 47

In-vitro/in-vivo correlation of pulsatile drug release from press-coated tablet formulations: A pharmacoscintigraphic study in the beagle dog

2007 · Manish Ghimire, Fiona J. McInnes, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 45

Characterisation and optimisation of diclofenac sodium orodispersible thin film formulation

2019 · Ibrahim Khadra, Mohammad A. Obeid, et al. · International Journal of Pharmaceutics · 44

PDF

Untargeted Metabolomics Profiling of an 80.5 km Simulated Treadmill Ultramarathon

2018 · Christopher Howe, Ahmed Alshehri, et al. · Metabolites · 44

PDF

Pharmacokinetics, Toxicities, and Efficacies of Sodium Stibogluconate Formulations after Intravenous Administration in Animals

2003 · J. Nieto, J. Alvar, et al. · Antimicrobial Agents and Chemotherapy · 44

Research is ‘a step into the unknown’: an exploration of pharmacists’ perceptions of factors impacting on research participation in the NHS

2015 · Richard Lowrie, Graeme Morrison, et al. · BMJ Open · 40

PDF

Comparison of the physical characteristics of monodisperse non-ionic surfactant vesicles (NISV) prepared using different manufacturing methods

2017 · Mohammad A. Obeid, Ayman M. Gebril, et al. · International Journal of Pharmaceutics · 38

PDF

Works count: 110

Citation count: 2,292

H-index: 30

I10-index: 55